Does Blinatumomab cause fever?

Blinatumomab is a biologic used to treat acute lymphoblastic leukemia (ALL). It affects the patient's immune system and helps it fight leukemia cells. Fever is a relatively common side effect in patients receiving belintuzumab, often due to the drug's immunostimulatory effects.

The mechanism of belintuzumab is to strengthen the immune system's response by connectingT cells and leukemia cells, thereby inducing the death of leukemia cells. However, this process may lead to activation of the immune system, triggering the body's inflammatory response, including fever.

Fever is a common treatment reaction called cytolytic reaction (Cytokine Release Syndrome, CRS). CRScan cause fever, headache, chills, muscle aches and other cold-like symptoms. The severity of fever can vary depending on individual patient differences and the dose of medication. In some cases, fever may become severe enough to require medical intervention and treatment.

The treatment team monitors the patient's temperature and symptoms to ensure fever does not escalate to life-threatening levels. Some patients may need antipyretic medications, such as acetaminophen, to relieve fever and discomfort. In addition, your doctor may take other steps, such as withholding or adjusting the dose of belintuzumab, to manage and reduce discomfort caused by CRS.

It is important to emphasize that fever, although a common side effect, is not necessarily a sign of treatment failure. It is often part of a treatment response and indicates that belintuzumab is priming the immune system to fight leukemia cells. During treatment, close monitoring and a closely coordinated medical team can effectively manage fever and other uncomfortable symptoms associated with belintuzumab to ensure optimal treatment outcomes for patients. Therefore, if you or a loved one is receiving this treatment, it is important to communicate with a medical professional for support and guidance.